开云体育
M. M. Ames
All authors
About
Publications While At 开云体育
selected publications
Journal Article
A Phase II randomized trial of panitumumab, erlotinib, and gemcitabine versus rrlotinib and hemcitabine in patients with nntreated, metastatic pancreatic adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
.
The oncologist.
2019
North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma
.
Cancer.
2017
Contact
full name
M. M.
Ames
Quick Info
Publications
Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science